| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 03/04/2004 | WO2004017922A2 Keto cannabinoids with therapeutic indications |
| 03/04/2004 | WO2004009015A3 Combination therapy for the treatment of obesity |
| 03/04/2004 | WO2004002980A3 Method for synthesizing coumarin and the derivatives thereof |
| 03/04/2004 | US20040044225 Chiral and achiral synthesis of 2-acyl substituted chromanes and their derivatives |
| 03/04/2004 | US20040044067 Anticholesterol agents; dietetics; plant extract |
| 03/04/2004 | US20040043498 Compounds prepared by introduction of fluorescence agent as means for measurement of singlet oxygen; superior in specificity and sensitivity |
| 03/04/2004 | US20040043083 Anticancer composition comprising sesquiterpenes isolated from resina ferulae |
| 03/04/2004 | CA2501719A1 Remedy or preventive for kidney disease and method of diagnosing kidney disease |
| 03/04/2004 | CA2496097A1 Keto cannabinoids with therapeutic indications |
| 03/03/2004 | EP1394156A1 Chromene compound |
| 03/03/2004 | EP1394144A1 Extraction of vitamin E, phytosterols and squalene from palm oil |
| 03/03/2004 | EP1392683A1 SUBSTITUTED 4 i H /i -CHROMENES AND ANALOGS AS ACTIVATORS OFGASP ASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF |
| 03/03/2004 | EP1392671A1 Process for the preparation of isoflavones |
| 03/03/2004 | EP1392644A1 Cinnamide derivatives as kcnq potassium channel modulators |
| 03/03/2004 | EP1392637A2 Modulators of peroxisome proliferator activated receptors |
| 03/03/2004 | EP1392284A2 Methods of treating hyperlipidemia |
| 03/03/2004 | EP1392283A1 Substituted coumarins and quinolines as caspases activators |
| 03/03/2004 | EP1153019B1 Photoactive propane derivatives and orientation layers |
| 03/03/2004 | EP0958288B1 Photochromic naphtopyrane colorants, method for the production and use thereof, photochromic object |
| 03/03/2004 | CN1478776A Extraction and purification technology of natural vitamin E |
| 03/03/2004 | CN1140525C 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 03/03/2004 | CN1140522C Benzodihydropyran derivative |
| 03/02/2004 | US6700002 As the catalyst in the reaction of trimethylhydroquinone with isophytol or phytol; no corrosion or toxicity problems |
| 03/02/2004 | US6700001 Process for stereoselective synthesis of 2-hydroxymethyl chromans |
| 03/02/2004 | US6699994 Biaryl compounds as serine protease inhibitors |
| 03/02/2004 | US6699891 Npyy5 antagonists |
| 03/02/2004 | US6699860 Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonists |
| 03/02/2004 | CA2221370C Composition for treating condyloma acuminata |
| 02/26/2004 | WO2004003510A3 Fluorescent dyes, energy transfer couples and methods |
| 02/26/2004 | WO2002081491A3 New genistein derivatives and pharmaceutical preparations containing them |
| 02/26/2004 | WO2002057211A8 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 02/26/2004 | WO2002041910A8 Methods and compositions for the treatment of diseases of the eye |
| 02/26/2004 | US20040039015 Estrogen Receptor-beta ligands |
| 02/26/2004 | US20040038977 Treating arthritis, pain and cancer |
| 02/26/2004 | US20040038974 Antiarthritic agents |
| 02/26/2004 | US20040038941 Compounds for the treatment of inflammatory disorders |
| 02/25/2004 | EP1391952A2 Salts of pentacyclic or tetrapentaline derived anions, and their uses as ionic conductive materials |
| 02/25/2004 | EP1390359A1 Synthesis of cannabinoids |
| 02/25/2004 | EP1390332A1 Uncatalysed addition reactions |
| 02/25/2004 | EP1301503B1 Coumarin derivatives with comt inhibiting activity |
| 02/25/2004 | EP1230232B1 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 02/25/2004 | EP0966684B1 Compounds for detecting phosphoric acid esters |
| 02/25/2004 | EP0965344B1 Prophylactic and therapeutic agent for inflammatory intestinal diseases |
| 02/25/2004 | CN1477147A Synthesis of oily chemical product with multifunctional group, its product and its application |
| 02/25/2004 | CN1477104A Extraction and purification method of licoflavone |
| 02/25/2004 | CN1139584C Heterocyclic compounds, method for preparing and medicine composition containing same |
| 02/25/2004 | CN1139384C Therapeutic composition based on flavonoids for use in treatment of tumours with cytotoxic agents |
| 02/25/2004 | CN1139383C Therapeutic composition containing isoflavonoids for process in treatment of tumours with cytotoxic agents |
| 02/24/2004 | US6696494 α-hydroxyarylbutanamine inhibitors of aspartyl protease |
| 02/24/2004 | US6696485 Cocoa extracts; antitumor, anticancer activity; oxidation resistance; dna topoisomerase ii enzyme inhibition |
| 02/24/2004 | US6696484 Method and compositions for regulation of 5-alpha reductase activity |
| 02/24/2004 | US6696459 Using high affinity, high selectivity quinoline derivativesw |
| 02/24/2004 | CA2250014C Asymmetric benzoxanthene dyes |
| 02/19/2004 | WO2004014886A1 Antigiardial agents and use thereof |
| 02/19/2004 | WO2004014880A1 Chromone derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2003089423A3 Novel flavanoids and chalcones as chemotherapeutic, chemopreventive, and antiangiogenic agents |
| 02/19/2004 | US20040034239 Inhibitors of nadh:ubiquinone oxidoreductase |
| 02/19/2004 | US20040034093 Methods for enhancing motor performance and/or endurance |
| 02/19/2004 | US20040034080 Comprises catalytic hydroformylation/hydrocarbonylation and reductive amination using a transition metal catalyst |
| 02/19/2004 | US20040034017 4-fluoroalkyl-2h-benzopyrans anti-estogenic activity |
| 02/19/2004 | US20040033514 Detection of disease related genes |
| 02/19/2004 | US20040033317 Surface-active photoinitators |
| 02/19/2004 | US20040033207 Cleansers of soaps, surfactants, detergents, and mixtures, and a soybean derived natural epidermal growth factor receptor inhibitor (egfr) |
| 02/19/2004 | CA2497658A1 Chromone derivatives as matrix metalloproteinase inhibitors |
| 02/18/2004 | EP1389202A1 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 02/18/2004 | EP1389189A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 02/18/2004 | EP1014968B1 NARINGIN AND NARINGENIN AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR |
| 02/18/2004 | EP0980365B1 method for the preparation of alpha-tocopherol-4-aminobenzoic acid ester compounds |
| 02/18/2004 | CN1476441A Method for continuously acylating chromanol ester derivatives |
| 02/18/2004 | CN1475488A Fluoro isoflavone containing derivative, monufacturing method and its use |
| 02/18/2004 | CN1475487A Fluoro flavon containing compound, manufacturing method and its use |
| 02/18/2004 | CN1138755C Cyclic amino acids and derivs thereof useful as pharmaceutical agents |
| 02/18/2004 | CN1138552C Polyphenol extract of tea, use thereof and formulations containing same |
| 02/17/2004 | US6692797 Photoactive pentaerythritol derivatives and orientation layers |
| 02/17/2004 | CA2124680C Piperazine derivatives as 5-ht1a antagonists |
| 02/12/2004 | WO2004013079A1 Ketocampholenic acid derivatives and their use in fragrance and flavour applications |
| 02/12/2004 | WO2004012682A2 2-heterosubstituted 3-aryl-4-h-1-benzopyran-4-ones as novel therapeutics in breast cancer |
| 02/12/2004 | WO2003049702A3 Vanilloid receptor ligands and their use in treatments |
| 02/12/2004 | US20040030194 Reacting hydrogen peroxide with 1-hydroperoxy-oxabicyclo(4.10.0)hexadecane in presence of copper catalyst |
| 02/12/2004 | US20040030166 Methods for treating deodorizer distillate |
| 02/12/2004 | US20040029954 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 02/12/2004 | US20040029914 Novel flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents |
| 02/12/2004 | US20040028758 Antioxidant composition and method of preparation thereof |
| 02/12/2004 | US20040026323 Method for chromatographic preparation of tocotrienol |
| 02/12/2004 | CA2497584A1 2-heterosubstituted 3-aryl-4h-1-benzopyran-4-ones as novel therapeutics in breast cancer |
| 02/11/2004 | EP1388534A2 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors |
| 02/11/2004 | EP1388343A1 Antioxidant composition and method of preparation thereof |
| 02/11/2004 | EP1387690A1 Use of extracts and preparations from iris plants and tectorigenin as medicaments |
| 02/11/2004 | EP1387677A2 Method of treating hematologic tumors and cancers using beta lapachone |
| 02/11/2004 | EP1328282A4 Efficient method for producing compositions enriched in anthocyanins |
| 02/11/2004 | EP0859608B1 Treating niddm with rxr agonists |
| 02/11/2004 | CN1474803A Novel amide derivatives and medicinal use thereof |
| 02/11/2004 | CN1474684A Cosmetic method of treating skin |
| 02/11/2004 | CN1473822A Extracting process of flavone and poly saccharide in duckweed |
| 02/11/2004 | CN1473814A Intemediate for preparing alkyl-dihalogeno phenyl substituted keto-enol |
| 02/11/2004 | CN1473809A Di-ether usedin preparation of Ziegler-Natta catalyst |
| 02/11/2004 | CN1473565A Benzopyrany/derivatives and antiallergic agent |
| 02/11/2004 | CN1137894C Pyridopyranoazepine derivatives, preparation and therapeutic use |
| 02/11/2004 | CN1137889C Novel tricycloacylamide compound, its preparation method and medicinal composition containing them |
| 02/11/2004 | CN1137629C Continuous technological process of extracting soybean separate protein, isoflavone, oligosaccharide and saponin |